Selenium and thyroid disease: From pathophysiology to treatment

International Journal of Endocrinology

Volumn 2017, Issue , 2017, Pages

  Ventura, Mara ^a   Melo, Miguel ^a,b   Carrilho, Francisco ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; LEVOTHYROXINE; SELENIUM; SELENOMETHIONINE; THYROID PEROXIDASE ANTIBODY;

AUTOIMMUNE THYROIDITIS; CLINICAL EFFECTIVENESS; DIETARY INTAKE; ECHOGRAPHY; ENDOCRINE OPHTHALMOPATHY; GRAVES DISEASE; HASHIMOTO DISEASE; HOMEOSTASIS; HUMAN; IMMUNITY; MINERAL SUPPLEMENTATION; MORTALITY RATE; NONHUMAN; NUTRITIONAL VALUE; PREGNANCY; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SELENIUM BLOOD LEVEL; THYROID DISEASE; THYROID FUNCTION; THYROID GLAND; THYROID NODULE; THYROTROPIN BLOOD LEVEL;

EID: 85013243983     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2017/1297658     Document Type: Review

References (53)

1. L. H. Duntas and S. Benvenga, "Selenium: An element for life, " Endocrine, vol. 48, no. 3, pp. 756-775, 2015.
2. M. P. Rayman, "Selenium and human health, " Lancet, vol. 379, no. 9822, pp. 1256-1268, 2012.
3. C. Thiry, A. Ruttens, L. Pussemier, and Y. J. Schneider, "An in vitro investigation of species-dependent intestinal transport of selenium and the impact of this process on selenium bioavailability, " The British Journal of Nutrition, vol. 109, no. 12, pp. 2126-2134, 2013.
4. N. Waegeneers, C. Thiry, L. De Temmerman, and A. Ruttens, "Predicted dietary intake of selenium by the general adult population in Belgium, " Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment, vol. 30, no. 2, pp. 278-285, 2013.
5. K. Park, E. Rimm, D. Siscovick, D. Spiegelman, J. S. Morris, and D. Mozaffarian, "Demographic and lifestyle factors and selenium levels in men and women in the U.S, " Nutrition Research and Practice, vol. 5, no. 4, pp. 357-364, 2011.
6. M. P. Rayman, "The use of high-selenium yeast to raise selenium status: how does it measure up?" The British Journal of Nutrition, vol. 92, no. 4, pp. 557-573, 2004.
7. A. P. Kipp, D. Strohm, R. Brigelius-Flohe et al., "Revised reference values for selenium intake, " Journal of Trace Elements in Medicine and Biology, vol. 32, pp. 195-199, 2015.
8. Institute of Medicine (US) Panel on Dietary Antioxidants and Related Compounds, "Vitamin C, vitamin E, selenium, and β-carotene and other carotenoids: overview, antioxidant definition, and relationship to chronic disease, " in Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids, N. A. P. (US), Ed., Washington (DC), USA, 2000.
9. Agency for Toxic Substances and Disease Registry (ATSDR), Toxicologic Profile for Selenium, US Department of Health and Human Services, Public Health Service, Atlanta, GA, USA, 2003.
10. J. K. MacFarquhar, D. L. Broussard, P. Melstrom et al., "Acute selenium toxicity associated with a dietary supplement, " Archives of Internal Medicine, vol. 170, no. 3, pp. 256-261, 2010.
11. P. Goyens, J. Golstein, B. Nsombola, H. Vis, and J. E. Dumont, "Selenium deficiency as a possible factor in the pathogenesis of myxoedematous endemic cretinism, " Acta Endocrinologica, vol. 114, no. 4, pp. 497-502, 1987.
12. J. Kohrle, "Thyrotropin (TSH) action on thyroid hormone deiodination and secretion: one aspect of thyrotropin regulation of thyroid cell biology, " Hormone and Metabolic Research Supplement, vol. 23, pp. 18-28, 1990.
13. R. C. Dickson and R. H. Tomlinson, "Selenium in blood and human tissues, " Clinica Chimica Acta, vol. 16, no. 2, pp. 311-321, 1967.
14. L. Schomburg, "Selenium, selenoproteins and the thyroid gland: interactions in health and disease, " Nature Reviews Endocrinology, vol. 8, no. 3, pp. 160-171, 2012.
15. L. Saranac, S. Zivanovic, B. Bjelakovic, H. Stamenkovic, M. Novak, and B. Kamenov, "Why is the thyroid so prone to autoimmune disease?" Hormone Research in Pædiatrics, vol. 75, no. 3, pp. 157-165, 2011.
16. A. Drutel, F. Archambeaud, and P. Caron, "Selenium and the thyroid gland: more good news for clinicians, " Clinical Endocrinology, vol. 78, no. 2, pp. 155-164, 2013.
17. A. Dharmasena, "Selenium supplementation in thyroid associated ophthalmopathy: An update, " International Journal of Ophthalmology, vol. 7, no. 2, pp. 365-375, 2014.
18. J. Kohrle, F. Jakob, B. Contempre, and J. E. Dumont, "Selenium, the thyroid, and the endocrine system, " Endocrine Reviews, vol. 26, no. 7, pp. 944-984, 2005.
19. R. Negro, "Selenium and thyroid autoimmunity, " Biologics, vol. 2, no. 2, pp. 265-273, 2008.
20. C. morSanmartin, D. Plano, M. Font, and J. A. Palop, "Selenium and clinical trials: new therapeutic evidence for multiple diseases, " Current Medicinal Chemistry, vol. 18, no. 30, pp. 4635-4650, 2011.
21. U. Schweizer, F. Streckfuss, P. Pelt et al., "Hepatically derived selenoprotein P is a key factor for kidney but not for brain selenium supply, " Biochemical Journal, vol. 386, Pt 2, pp. 221-226, 2005.
22. K. E. Hill, S. Wu, A. K. Motley et al., "Production of selenoprotein P (Sepp1) by hepatocytes is central to selenium homeostasis, " The Journal of Biological Chemistry, vol. 287, no. 48, pp. 40414-40424, 2012.
23. L. Schomburg, C. Riese, M. Michaelis et al., "Synthesis and metabolism of thyroid hormones is preferentially maintained in selenium-deficient transgenic mice, " Endocrinology, vol. 147, no. 3, pp. 1306-1313, 2006.
24. R. Gartner, B. C. Gasnier, J. W. Dietrich, B. Krebs, and M. W. Angstwurm, "Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations, " The Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 4, pp. 1687-1691, 2002.
25. L. H. Duntas, E. Mantzou, and D. A. Koutras, "Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis, " European Journal of Endocrinology, vol. 148, no. 4, pp. 389-393, 2003.
26. O. Turker, K. Kumanlioglu, I. Karapolat, and I. Dogan, "Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses, " The Journal of Endocrinology, vol. 190, no. 1, pp. 151-156, 2006.
27. R. Gartner and B. C. Gasnier, "Selenium in the treatment of autoimmune thyroiditis, " Bio Factors, vol. 19, no. 3-4, pp. 165-170, 2003.
28. D. Nacamulli, C. Mian, D. Petricca et al., "Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis, " Clinical Endocrinology, vol. 73, no. 4, pp. 535-539, 2010.
29. J.Mao, V. J. Pop, S. C. Bath, H. L.Vader, C.W. Redman, and M. P. Rayman, "Effect of low-dose selenium on thyroid autoimmunity and thyroid function in UK pregnant women with mild-Tomoderate iodine deficiency, " European Journal of Nutrition, vol. 55, no. 1, pp. 55-61, 2016.
30. R. Negro, G. Greco, T. Mangieri, A. Pezzarossa, D. Dazzi, and H. Hassan, "The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies, " The Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 4, pp. 1263-1268, 2007.
31. K. H. Winther, T. Watt, J. B. Bjorner et al., "The chronic autoimmune thyroiditis quality of life selenium trial (CATALYST): study protocol for a randomized controlled trial, " Trials, vol. 15, p. 115, 2014.
32. L. B. Rasmussen, L. Schomburg, J. Kohrle et al., "Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency, " European Journal of Endocrinology, vol. 164, no. 4, pp. 585-590, 2011.
33. H. Derumeaux, P. Valeix, K. Castetbon et al., "Association of selenium with thyroid volume and echostructure in 35-To 60-year-old French adults, " European Journal of Endocrinology, vol. 148, no. 3, pp. 309-315, 2003.
34. Q. Wu, M. P. Rayman, H. Lv et al., "Low population selenium status is associated with increased prevalence of thyroid disease, " The Journal of Clinical Endocrinology and Metabolism, vol. 100, no. 11, pp. 4037-4047, 2015.
35. V. B. Vrca, F. Skreb, I. Cepelak, Z. Romic, and L. Mayer, "Supplementation with antioxidants in the treatment of Graves' disease; the effect on glutathione peroxidase activity and concentration of selenium, " Clinica Chimica Acta, vol. 341, no. 1-2, pp. 55-63, 2004.
36. L. Wang, B. Wang, S. R. Chen et al., "Effect of selenium supplementation on recurrent hyperthyroidism caused by Graves' disease: A prospective pilot study, " Hormone and Metabolic Research, vol. 48, no. 9, pp. 559-564, 2016.
37. R. S. Bahn, "Graves' ophthalmopathy, " The New England Journal of Medicine, vol. 362, no. 8, pp. 726-738, 2010.
38. C. Marcocci, G. J. Kahaly, G. E. Krassas et al., "Selenium and the course of mild Graves' orbitopathy, " The New England Journal of Medicine, vol. 364, no. 20, pp. 1920-1931, 2011.
39. L. Bartalena, L. Baldeschi, K. Boboridis et al., "The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy, " European Thyroid Journal, vol. 5, no. 1, pp. 9-26, 2016.
40. B. A. Carlson, M. H. Yoo, R. K. Shrimali et al., "Role of selenium-containing proteins in T-cell and macrophage function, " The Proceedings of the Nutrition Society, vol. 69, no. 3, pp. 300-310, 2010.
41. L. Patrick, "Selenium biochemistry and cancer: A review of the literature, " Alternative Medicine Review, vol. 9, no. 3, pp. 239-258, 2004.
42. F. Shen, W. S. Cai, J. L. Li, Z. Feng, J. Cao, and B. Xu, "The association between serum levels of selenium, copper, and magnesium with thyroid cancer: A meta-Analysis, " Biological Trace Element Research, vol. 167, no. 2, pp. 225-235, 2015.
43. J. Jonklaas, M. Danielsen, and H. Wang, "A pilot study of serum selenium, vitamin D, and thyrotropin concentrations in patients with thyroid cancer, " Thyroid, vol. 23, no. 9, pp. 1079-1086, 2013.
44. M. P. Rayman and S. Stranges, "Epidemiology of selenium and type 2 diabetes: can we make sense of it?" Free Radical Biology & Medicine, vol. 65, pp. 1557-1564, 2013.
45. S. Stranges, A. Navas-Acien, M. P. Rayman, and E. Guallar, "Selenium status and cardiometabolic health: state of the evidence, " Nutrition, Metabolism, and Cardiovascular Diseases, vol. 20, no. 10, pp. 754-760, 2010.
46. C. R. Rocourt and W. H. Cheng, "Selenium supranutrition: Are the potential benefits of chemoprevention outweighed by the promotion of diabetes and insulin resistance?" Nutrients, vol. 5, no. 4, pp. 1349-1365, 2013.
47. J. Bleys, A. Navas-Acien, and E. Guallar, "Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults, " Archives of Internal Medicine, vol. 168, no. 4, pp. 404-410, 2008.
48. R. A. Sunde, E. Paterson, J. K. Evenson, K. M. Barnes, J. A. Lovegrove, and M. H. Gordon, "Longitudinal selenium status in healthy British adults: Assessment using biochemical and molecular biomarkers, " The British Journal of Nutrition, vol. 99, Suppl 3, pp. S37-S47, 2008.
49. S. Gonzalez, J. M. Huerta, S. Fernandez, E. M. Patterson, and C. Lasheras, "Food intake and serum selenium concentration in elderly people, " Annals of Nutrition & Metabolism, vol. 50, no. 2, pp. 126-131, 2006.
50. B. Emmanuelle, M. Virginie, S. Fabienne et al., "Selenium exposure in subjects living in areas with high selenium concentrated drinking water: Results of a French integrated exposure assessment survey, " Environment International, vol. 40, pp. 155-161, 2012.
51. L. Pograjc, V. Stibilj, and I. Falnoga, "Impact of intensive physical activity on selenium status, " Biological Trace Element Research, vol. 145, no. 3, pp. 291-299, 2012.
52. F. Valent, M. Horvat, D. Mazej, V. Stibilj, and F. Barbone, "Maternal diet and selenium concentration in human milk from an Italian population, " Journal of Epidemiology, vol. 21, no. 4, pp. 285-292, 2011.
53. C. M. Hughes, J. V. Woodside, C. McGartland, M. J. Roberts, D. P. Nicholls, and P. P. McKeown, "Nutritional intake and oxidative stress in chronic heart failure, " Nutrition, Metabolism, and Cardiovascular Diseases, vol. 22, no. 4, pp. 376-382, 2012.